Knee Stem Cell Injections: What’s the Difference Between PRP, BMAC, and SVF?
Knee Osteoarthritis Regenerative Injection Guide | Three options worth knowing before considering surgery
“My knees ache when I go down stairs, but surgery feels like too much. Are there other options?”
“PRP, BMAC, SVF — they’re all called ‘stem cell injections.’ How are they actually different?”
“Which one is right for my knee?”
📌 The Short Answer
For knee osteoarthritis, three regenerative injections are currently used in Korea: PRP (from blood), BMAC (from bone marrow), and SVF (from fat). All three have received official New Health Technology recognition in Korea, and the right choice depends on the degree of cartilage damage and the individual patient’s condition.
If you’ve been to a clinic for knee pain recently, you’ve probably heard these terms thrown around: PRP, BMAC, SVF. They sound similar, but they’re actually three quite different options — differing in where the material comes from, what’s in it, and which patients benefit most. PRP works best for some patients; BMAC for others; SVF for still others. Today, I’ll break down the differences in plain terms anyone can follow, and I’ll also cover what’s coming next: cultured stem cells (MSCs), which are on the horizon for Korea’s knee osteoarthritis indication.
✏️ About the Author — Dr. Joo
Hello, I’m Dr. Joo, a regenerative medicine specialist setting a new standard of recovery through stem cell therapy and regenerative medicine.
With 15 years of clinical experience as an emergency medicine specialist on the front lines of life-saving care, I now serve as a Principal Investigator at a Korean Ministry of Health & Welfare-designated Advanced Regenerative Medicine Institution. Through this blog, I share not just treatment information but a science-based vision of where regenerative medicine is going.
Dr. Joo’s Core Areas in Regenerative Medicine
- Anti-aging, aesthetics & hair loss: stem cell anti-aging protocols, stem cell hair therapy, facial skin boosters & fat grafting
- Joint regeneration: PRP (blood), BMAC (bone marrow), and SVF (adipose-derived) protocols for knee osteoarthritis
- Refractory disease research: investigating root-cause treatment mechanisms through advanced regenerative medicine
As an officially designated Advanced Regenerative Medicine Institution, our clinic is committed to improving patients’ quality of life through verified safety and cutting-edge medical technology.
What Knee Stem Cell Injections Really Are — The New Middle Ground Between Pills and Surgery
Knee stem cell injections are treatments that take a patient’s own blood, bone marrow, or fat — isolate the regenerative cells and growth factors — and deliver them into the damaged knee joint to reduce inflammation and support tissue repair. Under the umbrella of “stem cell injections” there are actually several distinct preparations, each containing a different mix of cells and signaling molecules.
Why did this kind of treatment emerge in the first place? For decades, knee osteoarthritis followed a predictable path: oral medications → hyaluronic acid injections → joint replacement surgery. The problem is, medications give inconsistent relief, hyaluronic acid wears off quickly, and surgery is a significant commitment. That left a large group of patients — roughly 70% of those in their 50s and 60s in my clinical experience — stuck in the middle: too advanced for pills alone, but not ready for surgery.
Regenerative knee injections were developed specifically to fill that gap. In Korea, the National Evidence-based Healthcare Collaborating Agency (NECA) has now reviewed and officially recognized all three as new health technologies, in stages over the past few years.
| Procedure | NECA Report | Date of Recognition in Korea |
|---|---|---|
| BMAC (Bone Marrow) | HTA-2023-39 | July 2023 (recognized first) |
| SVF (Adipose) | HTA-2024-24 | June 2024 |
| PRP (Blood) | HTA-2024-41 | November 2024 |
[Source: National Evidence-based Healthcare Collaborating Agency (NECA), New Health Technology Assessment Reports]
An important detail: all three were specifically recognized for moderate knee osteoarthritis (Kellgren-Lawrence grades 2–3). KL grading is the international X-ray-based system for staging knee osteoarthritis, and grades 2–3 represent that very “in-between” group — the patients for whom oral therapies have stopped working but surgery isn’t yet appropriate.
💡 Key Takeaway
Stem cell knee injections fill the gap between pills and surgery. Their biggest strength isn’t suppressing symptoms — it’s supporting the body’s own repair signals. All three (BMAC 2023, SVF 2024, PRP 2024) are now formally recognized new health technologies in Korea.
PRP vs. BMAC vs. SVF — A Simple Analogy to Tell Them Apart
The biggest difference among the three comes down to two questions: “Where does the material come from?” and “What’s in it — and how much?” Here’s an easy way to picture it.
An arthritic knee is a bit like having a small repair site inside the joint. To bring it back to working order, you need two things: ① signals that tell repair work to begin (growth factors), and ② actual workers to do the rebuilding (stem cells and regenerative cells). PRP, BMAC, and SVF differ in how many signals and how many workers they bring to that site.
| Type | Simple Analogy | What It Actually Means |
|---|---|---|
| PRP | Sending in lots of “work orders” | Growth factors only, very few cells |
| BMAC | Sending “work orders + a small repair crew” | Bone marrow stem cells + growth factors |
| SVF | Sending “work orders + a large repair team” | Adipose-derived stem cells + immune-modulating cells (high count) |
① PRP — The Easiest Entry Point
PRP (Platelet-Rich Plasma) is made by drawing blood from the arm, spinning it in a centrifuge, and concentrating the platelet-rich layer for injection into the knee. Platelets carry a rich load of growth factors — PDGF, TGF-β, VEGF — that quiet inflammation and stimulate repair.
A 2019 meta-analysis published in the American Journal of Sports Medicine reported that PRP outperformed hyaluronic acid for knee osteoarthritis in terms of pain and function over a 12-month period (Belk JW et al., 2019). With minimal procedural burden — just a blood draw — PRP often serves as the first-tier option in clinical practice.
② BMAC — A Repair Crew from the Bone Marrow
BMAC (Bone Marrow Aspirate Concentrate) is obtained by aspirating bone marrow from the iliac crest (pelvis) and concentrating it. Bone marrow contains stem cells (BMSCs) along with multiple regenerative cells and growth factors, giving it greater regenerative potential than PRP.
A 2020 multicenter study published in Cartilage reported that BMAC injections produced significant improvements in pain and function in knee osteoarthritis patients over 24 months of follow-up (Centeno C et al., 2020). The bone marrow aspiration step sounds intimidating, but it’s performed under local anesthesia and has a well-established safety profile in clinical practice.
③ SVF — The Largest Cell Team, Harvested from Fat
SVF (Stromal Vascular Fraction) is prepared from the patient’s own adipose tissue by isolating and concentrating stem cells and immune-modulating cells. Per unit of tissue, fat yields about 100 times more stem cells than bone marrow, giving SVF the highest regenerative potential of the three.
A 2022 clinical review in Stem Cells Translational Medicine summarized SVF for knee osteoarthritis as showing not only pain and function improvement but also some MRI-measurable preservation of cartilage thickness in selected studies (Pak J et al., 2022). The trade-off is a slightly longer procedure time, since fat needs to be harvested first.
Patients often ask, “So which one is best?” Honestly, none is universally superior. For patients whose pain is mainly inflammatory, PRP is often the most efficient choice. For those who need to rebuild the cartilage environment itself, BMAC or SVF is more appropriate. In practice, the right option is chosen based on each patient’s state — or sometimes layered in sequence, using PRP first to settle inflammation and then BMAC or SVF to drive repair.
💡 Key Takeaway
All three use the patient’s own tissue, so rejection is essentially a non-issue. But “which one is right for me” is always decided by accurate diagnosis — not by what sounds the strongest. Without understanding the root cause of the pain, the cartilage damage level, and any coexisting conditions, no injection will deliver its full potential.
What’s Coming Next — Cultured MSCs and the Diagnostic Foundation
Cultured MSC therapy means taking the patient’s harvested stem cells, expanding them many-fold in a laboratory over several weeks, and then re-injecting them. Compared to PRP, BMAC, and SVF — which are all “same-day, concentrate-and-inject” preparations — cultured MSCs represent the next step in the field.
Whereas freshly harvested preparations contain tens to hundreds of thousands of cells, culture expansion can produce cell counts in the hundreds of millions. In theory, more cells means stronger anti-inflammatory and regenerative signaling, which could open up new options for patients with more advanced disease or those needing repeat treatments.
An important note: as of 2026, cultured MSCs have not yet received formal approval in Korea for the knee osteoarthritis indication. The 2023 amendment to Korea’s Advanced Regenerative Medicine Act opened pathways for clinical research and structured patient access, and the regulatory bodies are reviewing safety and efficacy data in stages. Formal approval may be on a not-too-distant horizon, which would meaningfully expand the options available to Korean patients.
A 2021 review in Nature Reviews Rheumatology summarized that cultured MSCs, by abundantly secreting immunomodulatory and anti-inflammatory signals within the joint, can produce meaningful improvements in pain and function (Murphy MB et al., 2021).
📷 How Should the Diagnosis Be Done?
As treatment options expand, accurate diagnosis becomes more important, not less. The same knee pain can come from different sources, and the right treatment depends on identifying which. Here’s how knee osteoarthritis is typically evaluated in clinical practice.
| Diagnostic Tool | What It Shows | When Is It Used? |
|---|---|---|
| X-ray | Bone structure, joint space, KL grading | Routine (every patient) |
| Ultrasound | Joint inflammation, effusion, ligaments, tendons | Routine + real-time injection guidance |
| MRI | Detailed cartilage, meniscus, ligament evaluation | When needed (differential or precision) |
One detail that’s often underappreciated: ultrasound is what determines whether the injection actually lands in the right place. The same stem cell preparation can produce very different results depending on whether it’s delivered into the precise joint space or just “somewhere close.” In practice, X-ray and ultrasound work as a pair — X-ray for staging, ultrasound for both inflammation assessment and real-time procedural guidance. MRI is reserved for cases where additional precision or differential diagnosis is needed.
📖 Stem cells come in many forms depending on where they’re sourced and how they’re processed. If you’d like to understand the different types and mechanisms more clearly, this companion post, [Stem Cells Explained — Types and Mechanisms], walks through the foundational concepts in plain language. For patients who also struggle with frequent colds or lowered immunity, a regenerative-medicine perspective on recovery capacity may be a useful complementary approach as well.
🎯 Who Is the Right Candidate for Which Injection?
Once the diagnostic workup is complete, the next step is matching the patient to the right option. Common patterns I see in clinical practice break down roughly like this:
| Patient Pattern | Preferred Option | Reasoning |
|---|---|---|
| 40s–50s, post-exercise pain, KL 1–2 | PRP | Low procedural burden, efficient for inflammatory pain |
| 50s–60s, pain on stairs / waking, KL 2–3 | BMAC or SVF | Need to rebuild the cartilage environment |
| Previous PRP, effect didn’t last | Step up to BMAC / SVF | Stronger regenerative signaling required |
| Coexisting systemic inflammation | SVF (immunomodulation) | Rich in immune-modulating cells |
| KL 4, difficulty walking | Surgical consultation first | Regenerative injections have limited solo benefit |
What this table really shows is that under the single umbrella of “stem cell injections,” the actual choice varies dramatically from patient to patient. That’s why, in my view, the most important clinical principle isn’t the injection itself — it’s not performing the procedure when it isn’t the right answer. Even when a patient comes in asking for a specific treatment, the responsible path is to do a careful diagnosis first, decide whether it’s truly the right stage for that treatment, and honestly redirect them to a different priority if something else needs attention first.
💡 Key Takeaway
The sequence that produces real results is: accurate diagnosis (X-ray + ultrasound, MRI when needed) → patient-matched option → combine when warranted. Stem cell injections aren’t magic. They’re a recovery process built jointly by patient and physician.
Frequently Asked Questions (FAQ)
Q1. Does one knee stem cell injection last for life?
A. No. The effect typically lasts 1–2 years, and depending on individual response, a booster injection may be appropriate. Lasting results also depend on the basics — weight management, strength training, and avoiding activities that put excessive load on the cartilage.
Q2. Among PRP, BMAC, and SVF, which is most effective?
A. There’s no single “best.” The right option depends on the degree of cartilage damage and the nature of the pain, and the best choice for the same patient can change over time. Matching the option to the diagnosis is what determines outcomes.
Q3. Will stem cell injections regrow my worn-out cartilage?
A. To be honest, worn cartilage doesn’t regenerate to a newborn-like state. What these injections do is improve the inflammatory environment inside the joint, slow further cartilage loss, and meaningfully reduce pain and improve function. Some studies have observed measurable preservation of cartilage thickness on MRI.
Q4. When is it better not to have the procedure?
A. Patients with advanced (KL 4) osteoarthritis, near-immobile walking, active infections, or certain blood disorders are usually better served by alternative treatments. Also, knee pain isn’t always from the knee — the source can be the hip or lumbar spine, which is why diagnosis must rule those out first.
Q5. How long is the recovery after the procedure?
A. The procedure is outpatient. You can expect mild swelling or stiffness for 1–3 days, with most patients returning to normal daily activities within a week. The full effect is typically felt 4–8 weeks after the injection, as the regenerative signals do their work.
In Summary — Today’s Key Points
① Knee stem cell injections fill the gap between medications and surgery.
② In Korea, BMAC (July 2023), SVF (June 2024), and PRP (November 2024) are all officially recognized new health technologies.
③ Cultured MSCs may soon receive formal approval for the knee osteoarthritis indication in Korea, expanding the options available.
④ There’s no single “best” option. Accurate diagnosis (X-ray + ultrasound, MRI as needed) guides a patient-specific or combined approach.
⑤ The diagnosis comes first — not the procedure. Knowing when not to inject is what makes the difference in outcomes.
📌 Learn More About Dr. Joo & Saeron Clinic
If you’d like to explore further or get in touch, visit the links below.
👉 Dr. Joo’s Medical Philosophy → https://www.thesaeron.kr/eng/story/
👉 Saeron Clinic Official Website → https://www.thesaeron.kr/eng/
The information provided in this blog is for educational and informational purposes only. Individual treatment decisions should always be made in consultation with a qualified medical professional.
#KneeOsteoarthritis #KneePain #StemCellInjection #PRP #BMAC #SVF #RegenerativeMedicine #JointRegeneration #CartilageRepair #NonSurgicalKneeTreatment #OrthopedicCare #KneeArthritisTreatment #KoreanMedicalCare #AdvancedRegenerativeMedicine #CulturedMSC #KneeHealth #OrthobiologicTherapy #DrJoo #SaeronClinic
#DrJoo #SaeronClinic #StemCellKorea #Busan #KoreanMedicalTourism